[1] |
World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
|
[2] |
Jenkins HE, Yuen CM, Rodriguez CA, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis, 2017,17(3):285-295. doi: 10.1016/S1473-3099(16)30474-1.
doi: 10.1016/S1473-3099(16)30474-1
URL
pmid: 27964822
|
[3] |
Schaaf HS. Diagnosis and management of multidrug-resistant tuberculosis in children: a practical approach. Indian J Pediatr, 2019,86(8):717-724. doi: 10.1007/s12098-018-02846-8.
doi: 10.1007/s12098-018-02846-8
URL
pmid: 30656560
|
[4] |
Wang M, Liu F, Li Q, et al. Quality assessment of guidelines for the management of Mycobacterium tuberculosis infection in children. Int J Tuberc Lung Dis, 2020,24(3):287-294. doi: 10.5588/ijtld.19.0224.
doi: 10.5588/ijtld.19.0224
URL
pmid: 32228758
|
[5] |
Voss LM, Australasian Subgroup in Paediatric Infectious Disease of the Australasian Society for Infectious Diseases, Australasian Paediatric Respiratory Group. Management of tuberculosis in children. J Paediatr Child Health, 2000,36(6):530-536. doi: 10.1046/j.1440-1754.2000.00565.x.
doi: 10.1046/j.1440-1754.2000.00565.x
URL
pmid: 11115026
|
[6] |
Mellado Peña MJ, Santiago García B, Baquero-Artigao F, et al. Tuberculosis treatment for children: An update. An Pediatr (Barc), 2018, 88(1):52.e1-52.e12. doi: 10.1016/j.anpedi.2017.05.013.
doi: 10.1016/j.anpedi.2017.05.013
URL
|
[7] |
Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep, 2008,34(ACS-6):1-13.
URL
pmid: 18979589
|
[8] |
Lange C, Abubakar I, Alffenaar JW, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J, 2014,44(1):23-63. doi: 10.1183/09031936.00188313.
doi: 10.1183/09031936.00188313
URL
pmid: 24659544
|
[9] |
Jiang M, Guan WJ, Fang ZF, et al. A Critical Review of the Quality of Cough Clinical Practice Guidelines. Chest, 2016,150(4):777-788. doi: 10.1016/j.chest.2016.04.028.
doi: 10.1016/j.chest.2016.04.028
URL
pmid: 27164291
|
[10] |
张悦. 我国临床实践指南评价指标体系构建研究. 武汉: 华中科技大学, 2016. doi: 10.7666/d.D01074532.
|
[11] |
World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018.
|
[12] |
National Institute for Health and Care Excellence. Tuberculosis. London: National Institute for Health and Care Excellence, 2016.
|
[13] |
World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. Geneva: World Health Organization, 2016.
|
[14] |
World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. Geneva: World Health Organization, 2016.
|
[15] |
Santin M, García-García JM, Domínguez J, et al. Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection. Enferm Infecc Microbiol Clin, 2016, 34(5): 303.e1-13. doi: 10.1016/j.eimc.2015.11.022.
doi: 10.1016/j.eimc.2015.11.022
URL
|
[16] |
World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization, 2014.
|
[17] |
World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization, 2013.
|
[18] |
World Health Organization. WHO consolidated guidelines on tuberculosis, module 4: treatment-drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2020.
|
[19] |
Galli L, Lancella L, Garazzino S, et al. Recommendations for treating children with drug-resistant tuberculosis. Pharmacol Res, 2016,105:176-182. doi: 10.1016/j.phrs.2016.01.020.
doi: 10.1016/j.phrs.2016.01.020
URL
pmid: 26821118
|
[20] |
World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization, 2019.
|
[21] |
丁泓帆, 杨楠, 邓围, 等. WHO指南制定的基本原则和方法. 中国循证医学杂志, 2016,16(4):471-477. doi: 10.7507/1672-2531.20160072.
|
[22] |
解染, 陈耀龙, 陈昊, 等. 循证指南制定中患者价值观和偏好的研究方法. 中国循证医学杂志, 2015,15(5):586-591. doi: 10.7507/1672-2531.20150097.
|